IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction

This study has been terminated.
(Lack of funding)
Sponsor:
Information provided by (Responsible Party):
Steven P. Schulman, MD, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01532206
First received: February 9, 2012
Last updated: March 25, 2013
Last verified: March 2013

February 9, 2012
March 25, 2013
March 2013
February 2014   (final data collection date for primary outcome measure)
Interleukin 10 levels [ Time Frame: 24 hours following RIPC ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01532206 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction
Interleukin-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction.

Remote ischemic preconditioning has proven beneficial in patients undergoing percutaneous coronary intervention and coronary artery bypass surgery. Animal studies suggest remote ischemic preconditioning increases levels of interleukin 10. The investigators aim to determine whether remote ischemic preconditioning results in an increase in IL-10 levels in patients following acute myocardial infarction.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Acute Myocardial Infarction
Other: Blood pressure cuff insufflation
Blood pressure cuff will be inflated to a pressure of 200mmHg for 5 minutes. This will be repeated x 3, separated by 5 minutes.
  • Experimental: Remote ischemic preconditioning
    Remote ischemic preconditioning performed with Blood pressure cuff insufflation
    Intervention: Other: Blood pressure cuff insufflation
  • No Intervention: Standard of care
    Standard of care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
1
May 2014
February 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

- Acute myocardial infarction

Exclusion Criteria:

- Cardiogenic shock Active ischemia

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01532206
NA_00069912
No
Steven P. Schulman, MD, Johns Hopkins University
Johns Hopkins University
Not Provided
Principal Investigator: Steven P Schulman, MD Johns Hopkins University
Johns Hopkins University
March 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP